Search Results - Rong Fu

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Digital Transformation and Enterprise Innovation Capability: From the Perspectives of Enterprise Cooperative Culture and Innovative Culture by Tao Liu, Jiaxuan Leng, Shunyu Zhu, Rong Fu

    Published 2025-06-01

    Enterprise digital transformation has emerged as a key strategy for enhancing innovation capacity in the age of the digital economy. This article aims to analyze the influence mechanism of digital transformation on corporate innovation and evaluate the mediating function of corporate innovation and...

    Full description

    Get full text
    Article
  2. 2

    Budd-chiari syndrome associated with acute promyelocytic leukemia: a case and literature review by Honglei Wang, Jing Guan, Jia Zeng, Ting Wang, Xu Lang, Rong Fu

    Published 2025-12-01

    Background Acute promyelocytic leukemia (APL) is prone to hemorrhage and thrombosis during onset and induction treatment. Occasionally, severe and rare thrombosis can occur, which deserves our attention. Such as Budd-Chiari syndrome (BCS). BCS is a rare and severe disease caused by occlusion of the...

    Full description

    Get full text
    Article
  3. 3

    Comprehensive measurement of purines in biological samples by Rong Fu, Diane J. Sutcliffe, Ashok R. Dinasarapu, Ellen J. Hess, Ellen J. Hess, H. A. Jinnah, H. A. Jinnah

    Published 2025-07-01

    Defects in numerous aspects of purine metabolism are well-recognized causes for human diseases. The applicability of ultra performance liquid chromatography (UPLC) with photodiode array (PDA) detection for analysis of the most abundant biological relevant purines metabolites is described. This metho...

    Full description

    Get full text
    Article
  4. 4

    Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: Safety and tolerability in healthy Chinese participants by Yulei He, Fengli Zhao, Xiao Yang, Shasha Xing, Feifeng Xi, Fen Shen, Lin Yang, Guijun Ning, Fang Sun, Rui Wang, Qiong Shou, Rong Fu, Chang Chen, Anushua Sinha, Xueyan Liao

    Published 2025-12-01

    In China, respiratory syncytial virus (RSV) is the primary cause of acute lower respiratory tract infections (LRTIs), particularly in infants and young children. Clesrovimab is a half-life‒extended RSV neutralizing monoclonal antibody for the prevention of RSV-associated LRTIs in infants. This Phase...

    Full description

    Get full text
    Article
  5. 5